Cargando…

Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis

INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffensen, Ellen Hollands, Pedersen, Lars Henning, Lou, Stina, Vogel, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201969/
https://www.ncbi.nlm.nih.gov/pubmed/37186080
http://dx.doi.org/10.1111/aogs.14573
_version_ 1785045352801370112
author Steffensen, Ellen Hollands
Pedersen, Lars Henning
Lou, Stina
Vogel, Ida
author_facet Steffensen, Ellen Hollands
Pedersen, Lars Henning
Lou, Stina
Vogel, Ida
author_sort Steffensen, Ellen Hollands
collection PubMed
description INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevalence of congenital malformations, and early childhood morbidity of children with Down syndrome before and after implementation of this screening program. MATERIAL AND METHODS: A nationwide register‐based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biometry, prevalence of congenital malformations, and early childhood morbidity related to the implementation of a national prenatal screening program. RESULTS: We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z‐scores of birthweight and head circumference increased over time before screening, but this temporal development changed after implementation by −0.05 (95% confidence interval [CI]: −0.11 to 0.01) and −0.05 (95% CI −0.12 to 0.02), respectively. Just after implementation, the prevalence of non‐severe congenital heart disease decreased (relative change in odds 0.48 [95% CI: 0.24–0.94]). For severe congenital heart disease, atrioventricular septal defect, and non‐heart malformations, this change was 1.16 (95% CI: 0.56–2.41), 0.95 (95% CI: 0.43–2.03), and 0.98 (95% CI: 0.33–2.76), respectively. For all malformations, pre‐existing temporal developments did not change following implementation of screening. The implementation was associated with higher odds of admission to a neonatal intensive care unit (relative change 1.98 [95% CI: 0.76–5.26]) and an increased risk of hearing impairment (risk difference 3.4% [95% CI: −0.4% to 7.1%]). In contrast, the implementation was not associated with the incidence of hospital admissions by 2 years of age or with the probability of a thyroid disorder. CONCLUSIONS: After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non‐severe congenital heart disease; this result is, however, limited by small numbers.
format Online
Article
Text
id pubmed-10201969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102019692023-05-23 Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis Steffensen, Ellen Hollands Pedersen, Lars Henning Lou, Stina Vogel, Ida Acta Obstet Gynecol Scand Fetal Medicine INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevalence of congenital malformations, and early childhood morbidity of children with Down syndrome before and after implementation of this screening program. MATERIAL AND METHODS: A nationwide register‐based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biometry, prevalence of congenital malformations, and early childhood morbidity related to the implementation of a national prenatal screening program. RESULTS: We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z‐scores of birthweight and head circumference increased over time before screening, but this temporal development changed after implementation by −0.05 (95% confidence interval [CI]: −0.11 to 0.01) and −0.05 (95% CI −0.12 to 0.02), respectively. Just after implementation, the prevalence of non‐severe congenital heart disease decreased (relative change in odds 0.48 [95% CI: 0.24–0.94]). For severe congenital heart disease, atrioventricular septal defect, and non‐heart malformations, this change was 1.16 (95% CI: 0.56–2.41), 0.95 (95% CI: 0.43–2.03), and 0.98 (95% CI: 0.33–2.76), respectively. For all malformations, pre‐existing temporal developments did not change following implementation of screening. The implementation was associated with higher odds of admission to a neonatal intensive care unit (relative change 1.98 [95% CI: 0.76–5.26]) and an increased risk of hearing impairment (risk difference 3.4% [95% CI: −0.4% to 7.1%]). In contrast, the implementation was not associated with the incidence of hospital admissions by 2 years of age or with the probability of a thyroid disorder. CONCLUSIONS: After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non‐severe congenital heart disease; this result is, however, limited by small numbers. John Wiley and Sons Inc. 2023-04-25 /pmc/articles/PMC10201969/ /pubmed/37186080 http://dx.doi.org/10.1111/aogs.14573 Text en © 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Fetal Medicine
Steffensen, Ellen Hollands
Pedersen, Lars Henning
Lou, Stina
Vogel, Ida
Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title_full Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title_fullStr Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title_full_unstemmed Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title_short Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
title_sort impact of a prenatal screening program on the down syndrome phenotype: an interrupted time series analysis
topic Fetal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201969/
https://www.ncbi.nlm.nih.gov/pubmed/37186080
http://dx.doi.org/10.1111/aogs.14573
work_keys_str_mv AT steffensenellenhollands impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis
AT pedersenlarshenning impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis
AT loustina impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis
AT vogelida impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis
AT impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis